Follow the Supriya Lifescience Limited stock price and the full insider trade history of the company, a listed issuer based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Supriya Lifescience Limited has recorded 8 public disclosures. Market capitalisation: €69.8bn. The latest transaction was filed on 27 February 2024 (Purchase). Among the most active insiders: Satish Waman Wagh. All data is openly available.
8
Insider Decl.
n/a
Thresholds
€101,375
7 ops.
Buy Volume
n/a
1 ops.
Sell Volume
5Σ signal
Buys €101,375n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,762 of 29,064 companies
63.1
score / 100
Value
38
Quality
89
FCF yld0.5%
Earn yld3.0%
EV/EBITDA22.9x
ROE19%
Gross mgn69%
Net mgn25%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.